Characterization of a potential β-lactamase inhibitory metabolite from a marine Streptomyces sp. PM49 active against multidrug-resistant pathogens

Applied Biochemistry and Biotechnology
J ShanthiR Balagurunathan

Abstract

Actinobacteria is a prolific producer of complex natural products; we isolated a potential marine Streptomyces sp. PM49 strain from Bay of Bengal coastal area of India. The strain PM49 exhibited highly efficient antibacterial properties on multidrug-resistant pathogens with a zone of inhibition of 14-17 mm. SSF was adopted for the production of the secondary metabolites from PM49 with ISP2; utilizing agricultural wastes for compound extraction was also attempted. Bioactive fraction of Rf value 0.69 resolved using chloroform and ethyl acetate (1:1, v/v) was obtained and subjected to further analysis. Based on UV, IR, ESI-MS, and (1)H and (13)C NMR spectral analysis, it was revealed that the compound is closely similar to cyslabdan with a molecular mass of 467.66 corresponding to the molecular formula C25H41NO5S. ESBL and MBL production was screened in the hospital test isolates of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus. PCR amplification in the phenotypically positive strains was positive for bla IMP, bla SHV, bla CTX-M, and mec genes. The β-lactamase enzyme from tested strains had cephalosporinase activity with a 31-kDa protein and isolated compound from the strain poss...Continue Reading

References

Apr 12, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K LeeJ H Yum
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
May 31, 2002·Journal of Clinical Microbiology·F Javier Pérez-Pérez, Nancy D Hanson
Mar 25, 2005·Journal of Natural Products·Masashi TsudaJun'ichi Kobayashi
May 12, 2005·Journal of Biosciences·S K AugustineB P Kapadnis
Jun 14, 2005·Advanced Drug Delivery Reviews·Gerard D Wright
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Xiaofei JiangYuan Lu
Nov 17, 2006·Nature Chemical Biology·William Fenical, Paul R Jensen
Jan 16, 2007·Phytotherapy Research : PTR·Joseph Gangoué-PiébojiMoreno Galleni
Feb 20, 2007·International Journal of Antimicrobial Agents·Matthew E Falagas, Ioannis A Bliziotis
Feb 24, 2007·Journal of Natural Products·Shao Jie WuHartmut Laatsch
Apr 22, 2008·Nucleic Acids Research·A DereeperO Gascuel
Jul 26, 2008·Journal of the American Pharmacists Association : JAPhA·Daryl D DePestelJames A Hadley
Jun 6, 2009·Journal of Microbiology and Biotechnology·Moustafa Y El-NaggarSahar M Abdul-Gawad
Sep 2, 2010·Microbiology and Molecular Biology Reviews : MMBR·Julian Davies, Dorothy Davies
Feb 2, 2012·Microbiological Research·Venkata Ratna Ravi Kumar DasariSri Rami Reddy Donthireddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.